Erratum: Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial (J Am Coll Cardiol Img (2010) 3 (52-60))
Publication
, Journal Article
Patel, MR; Worthley, SG; Stebbins, A; Dill, T; Rademakers, FE; Velleti, US; Barsness, GW; Van De Werf, F; Hamm, CW; Armstrong, PW; Granger, CB ...
Published in: JACC: Cardiovascular Imaging
July 1, 2010
Duke Scholars
Published In
JACC: Cardiovascular Imaging
DOI
ISSN
1936-878X
Publication Date
July 1, 2010
Volume
3
Issue
7
Start / End Page
796
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Patel, M. R., Worthley, S. G., Stebbins, A., Dill, T., Rademakers, F. E., Velleti, U. S., … Kim, R. J. (2010). Erratum: Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial (J Am Coll Cardiol Img (2010) 3 (52-60)). JACC: Cardiovascular Imaging, 3(7), 796. https://doi.org/10.1016/j.jcmg.2010.05.006
Patel, M. R., S. G. Worthley, A. Stebbins, T. Dill, F. E. Rademakers, U. S. Velleti, G. W. Barsness, et al. “Erratum: Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial (J Am Coll Cardiol Img (2010) 3 (52-60)).” JACC: Cardiovascular Imaging 3, no. 7 (July 1, 2010): 796. https://doi.org/10.1016/j.jcmg.2010.05.006.
Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Velleti US, et al. Erratum: Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial (J Am Coll Cardiol Img (2010) 3 (52-60)). JACC: Cardiovascular Imaging. 2010 Jul 1;3(7):796.
Patel, M. R., et al. “Erratum: Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial (J Am Coll Cardiol Img (2010) 3 (52-60)).” JACC: Cardiovascular Imaging, vol. 3, no. 7, July 2010, p. 796. Scopus, doi:10.1016/j.jcmg.2010.05.006.
Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Velleti US, Barsness GW, Van De Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ. Erratum: Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial (J Am Coll Cardiol Img (2010) 3 (52-60)). JACC: Cardiovascular Imaging. 2010 Jul 1;3(7):796.
Published In
JACC: Cardiovascular Imaging
DOI
ISSN
1936-878X
Publication Date
July 1, 2010
Volume
3
Issue
7
Start / End Page
796
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology